Marshall Wace LLP Takes Position in Tempus AI, Inc. (NASDAQ:TEM)

Marshall Wace LLP purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEMFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 138,882 shares of the company’s stock, valued at approximately $4,861,000. Marshall Wace LLP owned about 0.08% of Tempus AI at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of TEM. Northwestern University acquired a new position in Tempus AI during the 2nd quarter worth approximately $491,000. WINTON GROUP Ltd acquired a new position in Tempus AI during the second quarter worth $634,000. EFG Asset Management North America Corp. purchased a new position in Tempus AI in the second quarter worth $1,333,000. Davidson Kempner Capital Management LP acquired a new stake in Tempus AI in the second quarter valued at $2,271,000. Finally, Pier Capital LLC acquired a new position in shares of Tempus AI during the 2nd quarter worth $2,301,000.

Analysts Set New Price Targets

A number of research firms have recently issued reports on TEM. JPMorgan Chase & Co. lifted their price target on shares of Tempus AI from $42.00 to $47.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Stifel Nicolaus began coverage on Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $45.00 price target for the company. Piper Sandler started coverage on shares of Tempus AI in a research report on Monday, August 12th. They issued a “neutral” rating and a $40.00 price objective on the stock. William Blair began coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set an “outperform” rating for the company. Finally, Loop Capital initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued a “buy” rating and a $48.00 price target on the stock. One investment analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $45.56.

Read Our Latest Research Report on Tempus AI

Tempus AI Price Performance

TEM stock opened at $53.07 on Wednesday. The stock has a 50 day moving average price of $49.90. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $77.00.

Tempus AI (NASDAQ:TEMGet Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing analysts’ consensus estimates of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. As a group, sell-side analysts expect that Tempus AI, Inc. will post -6.51 EPS for the current year.

Tempus AI Company Profile

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Further Reading

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.